Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Abivax (ABVX) Return on Sales: 2024-2025

  • Abivax's Return on Sales fell 627.00% to 11.64% in Q2 2025 from the same period last year, while for Jun 2025 it was 11.64%, marking a year-over-year decrease of 627.00%. This contributed to the annual value of -14.16% for FY2024, which is 1781.00% up from last year.
  • As of Q2 2025, Abivax's Return on Sales stood at 11.64%, which was down 13.28% from 13.42% recorded in Q1 2025.
  • In the past 5 years, Abivax's Return on Sales registered a high of 17.91% during Q2 2024, and its lowest value of 11.64% during Q2 2025.
  • Its 2-year average for Return on Sales is 14.54%, with a median of 14.32% in 2024.
  • Data for Abivax's Return on Sales shows a maximum YoY plummeted of 627bps (in 2025) over the last 5 years.
  • Quarterly analysis of 2 years shows Abivax's Return on Sales stood at 15.21% in 2024, then plummeted by 627bps to 11.64% in 2025.
  • Its Return on Sales stands at 11.64% for Q2 2025, versus 13.42% for Q1 2025 and 15.21% for Q4 2024.